BioCryst Pharmaceuticals | BCRX - EPS Earnings Per Share

Stock Price
9.86
Daily Change
0.20 2.07%
Monthly
24.81%
Yearly
26.41%
Q1 Forecast
9.41

BioCryst Pharmaceuticals reported $1.17 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Chugai Pharma JPY 78.03 10.45 Dec/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.21 0.51 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novavax USD 0.13 0.59 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025